NEXGEL

Executive Summary

NEXGEL, Inc. is a privately held company specializing in advanced hydrogel platform technology for drug delivery, wound care, and cosmetic applications. Headquartered in Langhorne, Pennsylvania, the company operates an FDA-registered and ISO-certified facility, enabling the manufacturing of hydrogel patches with or without active ingredients. Its versatile platform offers superior consumer experience through flexibility and customization, positioning it as a key player in the OTC medications, wound healing, and commercial product markets. With a strong regulatory foundation and a focus on patient comfort, NEXGEL is well-positioned to capture share in the growing hydrogel market. The company is currently expanding its product pipeline and seeking strategic partnerships to commercialize its technology across multiple segments. While still private and with limited public financials, NEXGEL's established manufacturing capabilities and regulatory compliance provide a solid base for growth. Near-term catalysts include new product clearances and potential collaborations with larger pharmaceutical or cosmetic firms. However, as a private entity, the company faces challenges in scaling and market penetration. Overall, NEXGEL represents a promising but early-stage opportunity in the hydrogel space.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) Clearance for New Wound Care Hydrogel Patch70% success
• Q4 2026Strategic Partnership with Major Pharma for OTC Drug Delivery60% success
• Q2 2026Commercial Launch of Hydrogel Cosmetic Product Line80% success